Unconventional wisdom: The boring income share I’m buying while investors fixate on AI
After learning a lesson from my CSL mistake, here’s how I’m applying it to find value in the parts of the market everyone else is ignoring.
Conventional wisdom is a byproduct of groupthink that presents solutions good enough for the average person while simultaneously not being right for any individual. You follow it at your peril. Each Monday I will challenge the investing norms that just may be holding you back from living the life you want.
Unconventional wisdom: The boring income share I’m buying while investors fixate on AI
We can learn from history, but we can also deceive ourselves when we selectively take evidence from the past to justify what we have already made up our minds to do.
- Margaret MacMillan
Picking individual shares is out of favour. There is seemingly a new record of inflows into ETFs each month.
Our recently released State of the Australian Investor report shows that many new investors are using ETFs as the core of their portfolios while older investors are using ETFs to supplement their core individual share holdings.
And I get it. I’ve been bombarded by the same data you have. Professionals are remarkably inept at beating the market so why join them in picking individual shares. My own portfolio reflects this trend as I’ve directed much of my recent savings into ETFs as well.
However, for my income growth strategy individual shares continue to make a lot of sense. Given the way fundamental income ETFs reconstitute their portfolios you can miss out on some of the compounding impact of income growth in an individual share.
If – and it is a challenge – you can find the right shares that grow their dividends you can compound your overall income at a high rate over the long-term.
I’ve come up with three lessons on the theory, market environment and share selection from the success and failures I’ve had picking individual shares which I outlined in last week’s column.
This is how I’m trying to navigate today’s AI driven market and some examples of shares I find attractive.
Lesson one: Contrarian investing can pay off if you avoid the pitfalls of this approach
Last week I cited several academic studies showing how narratives transform the way investors view markets and influence the shares they buy. With investors focused on one part of the market the out of favour areas can offer good opportunities.
The studies in my previous articles were based on data driven academically rigorous research. But the concept is not new and was first articulated by Economist John Maynard Keynes. The analogy Keyne used was a beauty contest. Instead of finding what is personally valuable investors too often try to guess what shares other investors will pick.
Professional investors like to use the jargony term ‘catalyst’ for this ‘beauty contest’ investing approach. In this way of thinking it isn’t good enough to find a share that meets your criteria. You also need to figure out what will cause other investors to buy the shares in the short-term so the price goes up.
One of the reasons why professional investors struggle to beat the market is because they need to consistently get these short-term catalysts right because short-term underperformance is punished.
The central issue in poor performance is not investing in individual shares but instead the structural pressures that force many professionals to invest in a certain way. I face none of those structural pressures.
But while I’m reflexively uncomfortable with the catalyst concept it does speak to the pitfalls of a contrarian approach. It takes patience for unloved parts of the market to regain investor interest. And investors could be ignoring shares for good reason. Being contrarian only works if out of favour shares eventually attract investor attention.
Lesson two: Following the herd feels safe but it can distort the underlying risk in a narrative
The media tends to focus on short-term relative performance between different parts of the market. I prefer taking a longer-term view to try and cut through this noise.
The following chart shows sector returns for the US market over the previous decade. If you’ve been paying attention, it isn’t a surprise that tech shares have meaningfully outperformed other sectors.

Source: Morningstar Investor November 2026
There have been several drivers for the success of tech shares. Over the last several years the narrative surrounding the advent of artificial intelligence has been instrumental in these outsized returns.
There is a lively and continuing debate over the investment implications of AI. Part of the reason why this debate is so fascinating is because of the unpredictability of the investment outcomes of the AI narrative.
In the latest of his insightful memos investing legend Howard Marks acknowledged how consequential AI will be but also raised several questions. These include:
What companies will benefit the most from AI? Will it be the current tech leaders, emerging companies or ones that haven’t been founded yet?
How profitable will AI related products be and how will profits be distributed across different players in the AI ecosystem? How many AI ‘units’ will be sold, at what price, and what is the cost per AI ‘unit’?
How quickly will AI adoption occur? Will AI models become commoditised and will price be the only way to compete?
His underlying point is that successful investing requires forecasting. But the predictability of different outcomes varies.
Some of the more predictable parts of the market have meaningfully underperformed including the consumer defensive, real estate and utilities sectors. Since I already have some AI exposure in my portfolio I am now turning to the unloved parts of the market.
Lesson three: High expectations can erode a margin of safety
An unpredictable outcome for an investment case does not eliminate it from consideration. The value of all investments are based on an unknown future. But the more uncertainty you are willing to accept the bigger the margin of safety needs to be.
How you view different parts of the market should be based on what you are trying to accomplish. In my case I’m trying to grow my passive income at a rate that meaningfully exceeds inflation.
The predictability of future earnings matters far more for income investors. Earnings and dividends are linked and if they vary significantly it puts the steady increase of passive income at risk.
That is why I’m particularly interested in the underperforming consumer defensive sector. In general consumer defensive earnings are steady because they sell products needed regardless of the state of the economy.
If the market is ignoring these sectors there may be an opportunity to pick up cheap shares with higher dividend yields. If I can buy a company with a strong dividend yield and there is a moderate amount of growth I can achieve my goals.
I’ve been turning repeatedly to these beaten down shares over the last several years. I’ve been buying spice maker McCormick and the out of favour Jack Daniels owner Brown-Forman. Lately I’ve added a new name to the list - Clorox.
Clorox produces various cleaning and household items as well as some salad dressings and sauces. There is nothing particularly consequential and transformative in their product portfolio.
Nothing about this investment will get people excited if I talk about it at a BBQ. Clorox doesn’t have the potential of an investment in Anthropic – but it also doesn’t have as many questions about what the company and industry will look like in ten years.
But if you see the world as I do there are some exciting things about Clorox. The shares have fallen more than 33% in the last five years and the dividend yield is just north of 4.50% compared to a 3.50% five-year average. More importantly, Clorox has raised their dividend for 49 consecutive years.
So why has Clorox underperformed the market to such a degree? The challenge faced by many name-brand consumer goods companies is the cost-of-living crisis and consumers switching to cheaper generic brands.
Clorox typically charges a 20% to 30% premium over generic brands and as a result the gross profit margin has typically been in the low 40% range. The gross profit margin measures the difference between revenue and the cost to produce the products sold by a company. This dynamic between price and cost is at the core of any business and is the basis for the questions Howard Marks is raising about AI.
Faced with generic competition, Clorox’s gross profit margin dipped to 35% in 2022. But it has since recovered to around 42% and our analyst cites a stout brand mix and scale advantages when assigning a Wide Moat Rating. This sustainable competitive advantage supports the long-term profit margins.
I keep coming back to a baseball analogy Warren Buffett liked to use when thinking about my investment in CSL. As an investor you can be patient as you want while waiting for the right pitch to swing at. I wasn’t patient enough with CSL.
The core lesson from my experience with CSL is to make sure I am being adequately compensated for the risk of things going wrong. When I bought the initial dip in CSL’s share price in 2023 the shares were still priced for a return to historic growth rates. When that didn’t happen the shares plunged.
Clorox’s dividend yield of roughly 4.50% provides some protection if things go wrong. There is also the strong financial condition of Clorox which results in an Exemplary Capital Allocation rating from our analysts.
Given the nature of the business there is less uncertainty about future outcomes with the main risk the competition from generic brands and input costs. Finally, there is the valution where the price to earnings has dropped 20% below the average level in the five years prior to the pandemic. Our analyst thinks the shares are trading at a 23% discount to our fair value as of 19 November 2026.
None of this means things won’t go wrong. Perhaps the market is right and Clorox faces a structural and permanent threat from generics. The shares may be priced approximately given those structural changes in the competitive balance. But unlike CSL I think there is an adequate margin of safety for this outcome.
Our analyst’s base case is for the dividend to grow at more than 3% for the next five years. If I reinvest dividends, the total income from my initial investment will grow at approximately 8% annually. This aligns with my goal of growing passive income at a rate faster than inflation.
If inflation falls and pressure on consumer pocketbooks goes down there could be further upside.
Final thoughts
The global and Australian market have hit a rough patch over the last several weeks. There is stubborn inflation and signs of economic slowdowns.
It is a reminder that at the heart of investing is decision making under uncertainty. I don’t know what will happen next and neither do you. The best any of us can do is try and be structured in the way we make decisions.
I’ve tried to do that by learning from my own mistakes and focusing on what I’m trying to accomplish.
A contrarian approach has always appealed to me. And with so many investors fixated on AI I am trying to take a different path. But simply doing what others don’t is not a guarantee of success. It was Howard Marks that summed this up perfectly:
While courage to take a different path enhances chances for success, investors face likely failure unless a thoughtful set of investment principles undergirds the courage.
A good reminder regardless of your investment strategy.
Questions, comments or restaurant recommendations? I can be reached at [email protected]
Get your finances on track with Invest Your Way
Our book Invest Your Way is available in 206 bookstores across Australia. Kindle and audiobook versions can also be purchased.
Invest Your Way is a personal finance book that combines foundational investing theory, real-world application and our own experiences. It is designed to help readers create a financial plan and investing strategy that is tailored to their unique goals and circumstances.
Get Mark’s insights in your inbox
Read more of Mark’s articles
Read previous editions of Unconventional wisdom
What I’ve been eating
Some readers may think ordering escargot is contrarian call. But when I went to dinner on Beaujolais nouveau day it felt appropriate to honour French culinary tradition. The snails arrived swimming in butter and garlic which is just how I like them. There was the necessary crusty baguette to soak up the sauce.
La Buvette is a new French wine bar in Potts Point and has a great wine list. I refrained from ordering an expensive Cru Beaujolais from Morgon and stuck with the cheap stuff. If things work out with my Clorox shares I might be back for that bottle.

